RNF7 and cancer: Furthermore, we investigated the association with RBX1/2 expression and immune subtypes in the TCGA pan-cancer data, illustrating that the expression of RBX1 was lowest in the C3 immune subtype, while RBX2 was lowest in the C5 immune subtype (Supplementary Figure 3).